The first experiment was conducted to determine if ABCC1 alters the extracellular metabolic profile of APP derivatives using transfected BE(2)-m17 human neuroblastoma cells (ATCC, Manassas, VA, USA). The gene discussed is ABCC1; the disease is neuroblastoma.